Manchester BIOGEL
PrivateCompany Overview
Manchester BIOGEL operates in Healthcare & Life Sciences and is based in Alderley Edge. It was founded in 2014.
Manchester BIOGEL is a biotechnology company that designs and manufactures synthetic peptide hydrogels for 3D cell culture, bioprinting, tissue regeneration, and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery, 3D Printing, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Manchester BIOGEL Comparables
Compare Manchester BIOGEL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheWell Bioscience | 93% | |
| Cellendes | 85% | |
| Cell Guidance Systems | 84% |
For institutional investors. Book with your work email.
Manchester BIOGEL Funding Rounds
Historical fundraising activity
Manchester BIOGEL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Manchester BIOGEL's valuation, stock price, and market status.
Is Manchester BIOGEL a public or private company?
Manchester BIOGEL is a private company.
What is the current stock price of Manchester BIOGEL?
Manchester BIOGEL is a private company, so its shares have no public market price. Caplight tracks Manchester BIOGEL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Manchester BIOGEL worth (valuation)?
Valuation information for Manchester BIOGEL is not publicly available.
Can I buy Manchester BIOGEL stock?
Manchester BIOGEL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Manchester BIOGEL's last funding round?
Funding round information for Manchester BIOGEL is not publicly available.
Who are the main investors in Manchester BIOGEL?
Investor information for Manchester BIOGEL is not publicly disclosed.
Will Manchester BIOGEL IPO soon?
No public IPO plans have been announced for Manchester BIOGEL.
How can I track Manchester BIOGEL secondary market activity?
Caplight tracks bids, offers, and trades in Manchester BIOGEL's shares on secondary markets.